J EUR ACAD DERMATOL 润色咨询

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

出版年份:1992 年文章数:2122 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:9.9% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1014039, encodeId=76cb10140393f, content=偏重的研究方向:性病<br>经验分享:Awaiting recommendation需要多久啊,一个星期了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:18:15 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:审稿审了两个月,两个意见一个小修一个大修,编辑给拒了,搞不懂,给的理由是没有足够的优先级,为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2110589, encodeId=782b211058982, content=11月25投稿,现在还显示Under review,不知道送外审了没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Tue Jan 17 16:38:36 CST 2023, time=2023-01-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向:皮肤病<br>经验分享:请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1014037, encodeId=7b97101403ed5, content=偏重的研究方向:性病<br>经验分享:想问一下为什么一直是Awaiting Recommendation?这个状态得多久啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:14:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134250, encodeId=8d6f2134250da, content=请问下大家Awaiting Admin Processing几天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40008358466, createdName=ms7000000363747460, createdTime=Mon May 15 15:01:49 CST 2023, time=2023-05-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2122344, encodeId=573e21223440c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:自身免疫性疱病<br>经验分享:2023年3月14日投,中间经历了under review,awaiting recommendation,28号变成Awaiting Decision,。。。。。。。紧张,是不是太快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def26469326, createdName=ms9000000353253855, createdTime=Tue Mar 28 20:52:34 CST 2023, time=2023-03-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1232374, encodeId=018a12323e443, content=审稿速度:2.0<br>偏重的研究方向:皮肤肿瘤<br>经验分享:2021/12/22 投稿<br>2022/2/21 一审意见,大修(给两个月时间)<br>2022/4/15 修改返回<br>2022/6/2 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu Jul 14 09:03:04 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584451, encodeId=a55c5844519f, content=我under review一个半月了,没有awaiting recommedation,是不是还没送外审需要催一下啊?<span class="quote">shaoting1183 2019-09-05 发表::<br>研究方向:scar;; 审稿时间:约1个月 6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。</span><span class="quote">shaoting1183 2019-09-05 14:55:00 发表:<br>6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。</span>, beContent=shaoting1183 2019-09-05 发表:: 研究方向:scar;; 审稿时间:约1个月 6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2872630811, createdName=1165917916, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=)]
    2021-09-02 起云

    偏重的研究方向:性病
    经验分享:Awaiting recommendation需要多久啊,一个星期了还是这样

    5

    展开5条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1014039, encodeId=76cb10140393f, content=偏重的研究方向:性病<br>经验分享:Awaiting recommendation需要多久啊,一个星期了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:18:15 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:审稿审了两个月,两个意见一个小修一个大修,编辑给拒了,搞不懂,给的理由是没有足够的优先级,为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2110589, encodeId=782b211058982, content=11月25投稿,现在还显示Under review,不知道送外审了没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Tue Jan 17 16:38:36 CST 2023, time=2023-01-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向:皮肤病<br>经验分享:请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1014037, encodeId=7b97101403ed5, content=偏重的研究方向:性病<br>经验分享:想问一下为什么一直是Awaiting Recommendation?这个状态得多久啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:14:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134250, encodeId=8d6f2134250da, content=请问下大家Awaiting Admin Processing几天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40008358466, createdName=ms7000000363747460, createdTime=Mon May 15 15:01:49 CST 2023, time=2023-05-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2122344, encodeId=573e21223440c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:自身免疫性疱病<br>经验分享:2023年3月14日投,中间经历了under review,awaiting recommendation,28号变成Awaiting Decision,。。。。。。。紧张,是不是太快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def26469326, createdName=ms9000000353253855, createdTime=Tue Mar 28 20:52:34 CST 2023, time=2023-03-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1232374, encodeId=018a12323e443, content=审稿速度:2.0<br>偏重的研究方向:皮肤肿瘤<br>经验分享:2021/12/22 投稿<br>2022/2/21 一审意见,大修(给两个月时间)<br>2022/4/15 修改返回<br>2022/6/2 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu Jul 14 09:03:04 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584451, encodeId=a55c5844519f, content=我under review一个半月了,没有awaiting recommedation,是不是还没送外审需要催一下啊?<span class="quote">shaoting1183 2019-09-05 发表::<br>研究方向:scar;; 审稿时间:约1个月 6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。</span><span class="quote">shaoting1183 2019-09-05 14:55:00 发表:<br>6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。</span>, beContent=shaoting1183 2019-09-05 发表:: 研究方向:scar;; 审稿时间:约1个月 6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2872630811, createdName=1165917916, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=)]
    2024-02-03 ms6000001766034942 来自山东省

    投着投着显示面板看不见稿件任何信息了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1014039, encodeId=76cb10140393f, content=偏重的研究方向:性病<br>经验分享:Awaiting recommendation需要多久啊,一个星期了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:18:15 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:审稿审了两个月,两个意见一个小修一个大修,编辑给拒了,搞不懂,给的理由是没有足够的优先级,为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2110589, encodeId=782b211058982, content=11月25投稿,现在还显示Under review,不知道送外审了没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Tue Jan 17 16:38:36 CST 2023, time=2023-01-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向:皮肤病<br>经验分享:请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1014037, encodeId=7b97101403ed5, content=偏重的研究方向:性病<br>经验分享:想问一下为什么一直是Awaiting Recommendation?这个状态得多久啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:14:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134250, encodeId=8d6f2134250da, content=请问下大家Awaiting Admin Processing几天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40008358466, createdName=ms7000000363747460, createdTime=Mon May 15 15:01:49 CST 2023, time=2023-05-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2122344, encodeId=573e21223440c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:自身免疫性疱病<br>经验分享:2023年3月14日投,中间经历了under review,awaiting recommendation,28号变成Awaiting Decision,。。。。。。。紧张,是不是太快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def26469326, createdName=ms9000000353253855, createdTime=Tue Mar 28 20:52:34 CST 2023, time=2023-03-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1232374, encodeId=018a12323e443, content=审稿速度:2.0<br>偏重的研究方向:皮肤肿瘤<br>经验分享:2021/12/22 投稿<br>2022/2/21 一审意见,大修(给两个月时间)<br>2022/4/15 修改返回<br>2022/6/2 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu Jul 14 09:03:04 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584451, encodeId=a55c5844519f, content=我under review一个半月了,没有awaiting recommedation,是不是还没送外审需要催一下啊?<span class="quote">shaoting1183 2019-09-05 发表::<br>研究方向:scar;; 审稿时间:约1个月 6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。</span><span class="quote">shaoting1183 2019-09-05 14:55:00 发表:<br>6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。</span>, beContent=shaoting1183 2019-09-05 发表:: 研究方向:scar;; 审稿时间:约1个月 6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2872630811, createdName=1165917916, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=)]
    2023-10-31 ms3000000179629265 来自山西省

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享:审稿审了两个月,两个意见一个小修一个大修,编辑给拒了,搞不懂,给的理由是没有足够的优先级,为什么不刚开始就拒了。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1014039, encodeId=76cb10140393f, content=偏重的研究方向:性病<br>经验分享:Awaiting recommendation需要多久啊,一个星期了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:18:15 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:审稿审了两个月,两个意见一个小修一个大修,编辑给拒了,搞不懂,给的理由是没有足够的优先级,为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2110589, encodeId=782b211058982, content=11月25投稿,现在还显示Under review,不知道送外审了没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Tue Jan 17 16:38:36 CST 2023, time=2023-01-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向:皮肤病<br>经验分享:请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1014037, encodeId=7b97101403ed5, content=偏重的研究方向:性病<br>经验分享:想问一下为什么一直是Awaiting Recommendation?这个状态得多久啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:14:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134250, encodeId=8d6f2134250da, content=请问下大家Awaiting Admin Processing几天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40008358466, createdName=ms7000000363747460, createdTime=Mon May 15 15:01:49 CST 2023, time=2023-05-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2122344, encodeId=573e21223440c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:自身免疫性疱病<br>经验分享:2023年3月14日投,中间经历了under review,awaiting recommendation,28号变成Awaiting Decision,。。。。。。。紧张,是不是太快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def26469326, createdName=ms9000000353253855, createdTime=Tue Mar 28 20:52:34 CST 2023, time=2023-03-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1232374, encodeId=018a12323e443, content=审稿速度:2.0<br>偏重的研究方向:皮肤肿瘤<br>经验分享:2021/12/22 投稿<br>2022/2/21 一审意见,大修(给两个月时间)<br>2022/4/15 修改返回<br>2022/6/2 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu Jul 14 09:03:04 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584451, encodeId=a55c5844519f, content=我under review一个半月了,没有awaiting recommedation,是不是还没送外审需要催一下啊?<span class="quote">shaoting1183 2019-09-05 发表::<br>研究方向:scar;; 审稿时间:约1个月 6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。</span><span class="quote">shaoting1183 2019-09-05 14:55:00 发表:<br>6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。</span>, beContent=shaoting1183 2019-09-05 发表:: 研究方向:scar;; 审稿时间:约1个月 6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2872630811, createdName=1165917916, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=)]
    2023-01-17 1256aa6cm86暂无昵称 来自陕西省

    11月25投稿,现在还显示Under review,不知道送外审了没

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1014039, encodeId=76cb10140393f, content=偏重的研究方向:性病<br>经验分享:Awaiting recommendation需要多久啊,一个星期了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:18:15 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:审稿审了两个月,两个意见一个小修一个大修,编辑给拒了,搞不懂,给的理由是没有足够的优先级,为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2110589, encodeId=782b211058982, content=11月25投稿,现在还显示Under review,不知道送外审了没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Tue Jan 17 16:38:36 CST 2023, time=2023-01-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向:皮肤病<br>经验分享:请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1014037, encodeId=7b97101403ed5, content=偏重的研究方向:性病<br>经验分享:想问一下为什么一直是Awaiting Recommendation?这个状态得多久啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:14:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134250, encodeId=8d6f2134250da, content=请问下大家Awaiting Admin Processing几天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40008358466, createdName=ms7000000363747460, createdTime=Mon May 15 15:01:49 CST 2023, time=2023-05-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2122344, encodeId=573e21223440c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:自身免疫性疱病<br>经验分享:2023年3月14日投,中间经历了under review,awaiting recommendation,28号变成Awaiting Decision,。。。。。。。紧张,是不是太快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def26469326, createdName=ms9000000353253855, createdTime=Tue Mar 28 20:52:34 CST 2023, time=2023-03-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1232374, encodeId=018a12323e443, content=审稿速度:2.0<br>偏重的研究方向:皮肤肿瘤<br>经验分享:2021/12/22 投稿<br>2022/2/21 一审意见,大修(给两个月时间)<br>2022/4/15 修改返回<br>2022/6/2 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu Jul 14 09:03:04 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584451, encodeId=a55c5844519f, content=我under review一个半月了,没有awaiting recommedation,是不是还没送外审需要催一下啊?<span class="quote">shaoting1183 2019-09-05 发表::<br>研究方向:scar;; 审稿时间:约1个月 6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。</span><span class="quote">shaoting1183 2019-09-05 14:55:00 发表:<br>6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。</span>, beContent=shaoting1183 2019-09-05 发表:: 研究方向:scar;; 审稿时间:约1个月 6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2872630811, createdName=1165917916, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=)]
    2023-08-24 941739541 来自天津

    偏重的研究方向:皮肤病
    经验分享:请问半个月就awiting decision 是不是都没有送外审🤣

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1014039, encodeId=76cb10140393f, content=偏重的研究方向:性病<br>经验分享:Awaiting recommendation需要多久啊,一个星期了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:18:15 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:审稿审了两个月,两个意见一个小修一个大修,编辑给拒了,搞不懂,给的理由是没有足够的优先级,为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2110589, encodeId=782b211058982, content=11月25投稿,现在还显示Under review,不知道送外审了没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Tue Jan 17 16:38:36 CST 2023, time=2023-01-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向:皮肤病<br>经验分享:请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1014037, encodeId=7b97101403ed5, content=偏重的研究方向:性病<br>经验分享:想问一下为什么一直是Awaiting Recommendation?这个状态得多久啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:14:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134250, encodeId=8d6f2134250da, content=请问下大家Awaiting Admin Processing几天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40008358466, createdName=ms7000000363747460, createdTime=Mon May 15 15:01:49 CST 2023, time=2023-05-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2122344, encodeId=573e21223440c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:自身免疫性疱病<br>经验分享:2023年3月14日投,中间经历了under review,awaiting recommendation,28号变成Awaiting Decision,。。。。。。。紧张,是不是太快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def26469326, createdName=ms9000000353253855, createdTime=Tue Mar 28 20:52:34 CST 2023, time=2023-03-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1232374, encodeId=018a12323e443, content=审稿速度:2.0<br>偏重的研究方向:皮肤肿瘤<br>经验分享:2021/12/22 投稿<br>2022/2/21 一审意见,大修(给两个月时间)<br>2022/4/15 修改返回<br>2022/6/2 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu Jul 14 09:03:04 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584451, encodeId=a55c5844519f, content=我under review一个半月了,没有awaiting recommedation,是不是还没送外审需要催一下啊?<span class="quote">shaoting1183 2019-09-05 发表::<br>研究方向:scar;; 审稿时间:约1个月 6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。</span><span class="quote">shaoting1183 2019-09-05 14:55:00 发表:<br>6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。</span>, beContent=shaoting1183 2019-09-05 发表:: 研究方向:scar;; 审稿时间:约1个月 6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2872630811, createdName=1165917916, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=)]
    2021-09-02 起云

    偏重的研究方向:性病
    经验分享:想问一下为什么一直是Awaiting Recommendation?这个状态得多久啊

    6

    展开6条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1014039, encodeId=76cb10140393f, content=偏重的研究方向:性病<br>经验分享:Awaiting recommendation需要多久啊,一个星期了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:18:15 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:审稿审了两个月,两个意见一个小修一个大修,编辑给拒了,搞不懂,给的理由是没有足够的优先级,为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2110589, encodeId=782b211058982, content=11月25投稿,现在还显示Under review,不知道送外审了没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Tue Jan 17 16:38:36 CST 2023, time=2023-01-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向:皮肤病<br>经验分享:请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1014037, encodeId=7b97101403ed5, content=偏重的研究方向:性病<br>经验分享:想问一下为什么一直是Awaiting Recommendation?这个状态得多久啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:14:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134250, encodeId=8d6f2134250da, content=请问下大家Awaiting Admin Processing几天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40008358466, createdName=ms7000000363747460, createdTime=Mon May 15 15:01:49 CST 2023, time=2023-05-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2122344, encodeId=573e21223440c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:自身免疫性疱病<br>经验分享:2023年3月14日投,中间经历了under review,awaiting recommendation,28号变成Awaiting Decision,。。。。。。。紧张,是不是太快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def26469326, createdName=ms9000000353253855, createdTime=Tue Mar 28 20:52:34 CST 2023, time=2023-03-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1232374, encodeId=018a12323e443, content=审稿速度:2.0<br>偏重的研究方向:皮肤肿瘤<br>经验分享:2021/12/22 投稿<br>2022/2/21 一审意见,大修(给两个月时间)<br>2022/4/15 修改返回<br>2022/6/2 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu Jul 14 09:03:04 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584451, encodeId=a55c5844519f, content=我under review一个半月了,没有awaiting recommedation,是不是还没送外审需要催一下啊?<span class="quote">shaoting1183 2019-09-05 发表::<br>研究方向:scar;; 审稿时间:约1个月 6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。</span><span class="quote">shaoting1183 2019-09-05 14:55:00 发表:<br>6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。</span>, beContent=shaoting1183 2019-09-05 发表:: 研究方向:scar;; 审稿时间:约1个月 6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2872630811, createdName=1165917916, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=)]
    2023-05-15 ms7000000363747460 来自湖南省

    请问下大家Awaiting Admin Processing几天

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1014039, encodeId=76cb10140393f, content=偏重的研究方向:性病<br>经验分享:Awaiting recommendation需要多久啊,一个星期了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:18:15 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:审稿审了两个月,两个意见一个小修一个大修,编辑给拒了,搞不懂,给的理由是没有足够的优先级,为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2110589, encodeId=782b211058982, content=11月25投稿,现在还显示Under review,不知道送外审了没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Tue Jan 17 16:38:36 CST 2023, time=2023-01-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向:皮肤病<br>经验分享:请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1014037, encodeId=7b97101403ed5, content=偏重的研究方向:性病<br>经验分享:想问一下为什么一直是Awaiting Recommendation?这个状态得多久啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:14:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134250, encodeId=8d6f2134250da, content=请问下大家Awaiting Admin Processing几天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40008358466, createdName=ms7000000363747460, createdTime=Mon May 15 15:01:49 CST 2023, time=2023-05-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2122344, encodeId=573e21223440c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:自身免疫性疱病<br>经验分享:2023年3月14日投,中间经历了under review,awaiting recommendation,28号变成Awaiting Decision,。。。。。。。紧张,是不是太快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def26469326, createdName=ms9000000353253855, createdTime=Tue Mar 28 20:52:34 CST 2023, time=2023-03-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1232374, encodeId=018a12323e443, content=审稿速度:2.0<br>偏重的研究方向:皮肤肿瘤<br>经验分享:2021/12/22 投稿<br>2022/2/21 一审意见,大修(给两个月时间)<br>2022/4/15 修改返回<br>2022/6/2 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu Jul 14 09:03:04 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584451, encodeId=a55c5844519f, content=我under review一个半月了,没有awaiting recommedation,是不是还没送外审需要催一下啊?<span class="quote">shaoting1183 2019-09-05 发表::<br>研究方向:scar;; 审稿时间:约1个月 6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。</span><span class="quote">shaoting1183 2019-09-05 14:55:00 发表:<br>6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。</span>, beContent=shaoting1183 2019-09-05 发表:: 研究方向:scar;; 审稿时间:约1个月 6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2872630811, createdName=1165917916, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=)]
    2023-03-28 ms9000000353253855 来自山东省

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:自身免疫性疱病
    经验分享:2023年3月14日投,中间经历了under review,awaiting recommendation,28号变成Awaiting Decision,。。。。。。。紧张,是不是太快了

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1014039, encodeId=76cb10140393f, content=偏重的研究方向:性病<br>经验分享:Awaiting recommendation需要多久啊,一个星期了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:18:15 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:审稿审了两个月,两个意见一个小修一个大修,编辑给拒了,搞不懂,给的理由是没有足够的优先级,为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2110589, encodeId=782b211058982, content=11月25投稿,现在还显示Under review,不知道送外审了没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Tue Jan 17 16:38:36 CST 2023, time=2023-01-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向:皮肤病<br>经验分享:请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1014037, encodeId=7b97101403ed5, content=偏重的研究方向:性病<br>经验分享:想问一下为什么一直是Awaiting Recommendation?这个状态得多久啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:14:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134250, encodeId=8d6f2134250da, content=请问下大家Awaiting Admin Processing几天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40008358466, createdName=ms7000000363747460, createdTime=Mon May 15 15:01:49 CST 2023, time=2023-05-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2122344, encodeId=573e21223440c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:自身免疫性疱病<br>经验分享:2023年3月14日投,中间经历了under review,awaiting recommendation,28号变成Awaiting Decision,。。。。。。。紧张,是不是太快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def26469326, createdName=ms9000000353253855, createdTime=Tue Mar 28 20:52:34 CST 2023, time=2023-03-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1232374, encodeId=018a12323e443, content=审稿速度:2.0<br>偏重的研究方向:皮肤肿瘤<br>经验分享:2021/12/22 投稿<br>2022/2/21 一审意见,大修(给两个月时间)<br>2022/4/15 修改返回<br>2022/6/2 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu Jul 14 09:03:04 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584451, encodeId=a55c5844519f, content=我under review一个半月了,没有awaiting recommedation,是不是还没送外审需要催一下啊?<span class="quote">shaoting1183 2019-09-05 发表::<br>研究方向:scar;; 审稿时间:约1个月 6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。</span><span class="quote">shaoting1183 2019-09-05 14:55:00 发表:<br>6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。</span>, beContent=shaoting1183 2019-09-05 发表:: 研究方向:scar;; 审稿时间:约1个月 6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2872630811, createdName=1165917916, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=)]
    2022-07-14 小胖子罗军

    审稿速度:2.0
    偏重的研究方向:皮肤肿瘤
    经验分享:2021/12/22 投稿
    2022/2/21 一审意见,大修(给两个月时间)
    2022/4/15 修改返回
    2022/6/2 接收

    4

    展开4条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1014039, encodeId=76cb10140393f, content=偏重的研究方向:性病<br>经验分享:Awaiting recommendation需要多久啊,一个星期了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:18:15 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2185714, encodeId=d6372185e1472, content=投着投着显示面板看不见稿件任何信息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399a6560316, createdName=ms6000001766034942, createdTime=Sat Feb 03 21:33:26 CST 2024, time=2024-02-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165986, encodeId=6f7e2165986e8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:审稿审了两个月,两个意见一个小修一个大修,编辑给拒了,搞不懂,给的理由是没有足够的优先级,为什么不刚开始就拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33086557288, createdName=ms3000000179629265, createdTime=Tue Oct 31 23:20:19 CST 2023, time=2023-10-31, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2110589, encodeId=782b211058982, content=11月25投稿,现在还显示Under review,不知道送外审了没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8042563609, createdName=1256aa6cm86暂无昵称, createdTime=Tue Jan 17 16:38:36 CST 2023, time=2023-01-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2154362, encodeId=c0a82154362e8, content=偏重的研究方向:皮肤病<br>经验分享:请问半个月就awiting decision 是不是都没有送外审🤣, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c374662724, createdName=941739541, createdTime=Thu Aug 24 14:02:50 CST 2023, time=2023-08-24, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1014037, encodeId=7b97101403ed5, content=偏重的研究方向:性病<br>经验分享:想问一下为什么一直是Awaiting Recommendation?这个状态得多久啊<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/19/e9c0f6fad56615afd529fbac5c772af1.jpg, createdBy=09d81705896, createdName=起云, createdTime=Thu Sep 02 20:14:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134250, encodeId=8d6f2134250da, content=请问下大家Awaiting Admin Processing几天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40008358466, createdName=ms7000000363747460, createdTime=Mon May 15 15:01:49 CST 2023, time=2023-05-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2122344, encodeId=573e21223440c, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:自身免疫性疱病<br>经验分享:2023年3月14日投,中间经历了under review,awaiting recommendation,28号变成Awaiting Decision,。。。。。。。紧张,是不是太快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def26469326, createdName=ms9000000353253855, createdTime=Tue Mar 28 20:52:34 CST 2023, time=2023-03-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1232374, encodeId=018a12323e443, content=审稿速度:2.0<br>偏重的研究方向:皮肤肿瘤<br>经验分享:2021/12/22 投稿<br>2022/2/21 一审意见,大修(给两个月时间)<br>2022/4/15 修改返回<br>2022/6/2 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu Jul 14 09:03:04 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584451, encodeId=a55c5844519f, content=我under review一个半月了,没有awaiting recommedation,是不是还没送外审需要催一下啊?<span class="quote">shaoting1183 2019-09-05 发表::<br>研究方向:scar;; 审稿时间:约1个月 6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。</span><span class="quote">shaoting1183 2019-09-05 14:55:00 发表:<br>6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。</span>, beContent=shaoting1183 2019-09-05 发表:: 研究方向:scar;; 审稿时间:约1个月 6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2872630811, createdName=1165917916, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=)]
    2020-02-09 1165917916

    我under review一个半月了,没有awaiting recommedation,是不是还没送外审需要催一下啊?shaoting1183 2019-09-05 发表::
    研究方向:scar;; 审稿时间:约1个月 6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。
    shaoting1183 2019-09-05 14:55:00 发表:
    6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。

    shaoting1183 2019-09-05 发表:: 研究方向:scar;; 审稿时间:约1个月 6月26投稿,当天under review,7月底 awaiting decision。8月7日 minor revision,无需补任何实验,只需要回答几个问题,修改一点文字。由于在休假,8月14日才返修回去,然后under review,9月2日 awaiting decision。9月4日accept。算是比较顺利了。因为文章之前投了一个1区的杂志,来回返修了三次,补了巨多实验,耗费半年时间,还是被拒了。有了那个基础,投这个二区的就比较顺利了。审稿速度很快,就是第一次awaiting decision比较久,基本快两周了,当时还有点慌。

    2

    展开2条回复
共78条页码: 1/8页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分